A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is extracorporeal membrane oxygenation (ECMO) superior to dedicated ventricular assist device (VAD) in patients with acutely failing allograft following transplantation. Altogether, 162 papers were found using the reported search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Two studies provide data only for ECMO-treated patients, in three, the authors describe their experiences with Levitronix CentriMag and three studies directly compare the outcomes of ECMO and VAD support. The survival ranges from 40 to 74% in patients rescued with ECMO compared with 33-60% in patients supported with dedicated VAD. We conclude that there is insufficient evidence to prefer ECMO over VAD and the optimal modality of mechanical circulatory support (MCS) following heart transplantation should be determined by the surgeon and institutional experience and dependent on the extent and severity of myocardial dysfunction and the presence or absence of associated respiratory insufficiency.
- MeSH
- Survival Analysis MeSH
- Benchmarking MeSH
- Time Factors MeSH
- Ventricular Function, Left MeSH
- Ventricular Function, Right MeSH
- Hemodynamics MeSH
- Ventricular Dysfunction mortality physiopathology therapy MeSH
- Humans MeSH
- Evidence-Based Medicine MeSH
- Extracorporeal Membrane Oxygenation * adverse effects mortality MeSH
- Heart-Assist Devices * MeSH
- Respiratory Insufficiency etiology MeSH
- Risk Factors MeSH
- Heart Transplantation adverse effects mortality MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
